Physicians' assessments of the utility of health states associated with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) Infection

Quality of Life Research

Volumn 6, Issue 1, 1997, Pages 77-86

  Owens, D K ^a,b,c   Cardinalli, A B ^a   Nease Jr , R F ^d  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acquired immunodeficiency syndrome; cost benefit analyses; HIV; HIV infections; patient preferences; physicians; quality of life

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; HEALTH STATUS; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT ATTITUDE; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ATTITUDE TO HEALTH; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HEPATITIS B; HIV INFECTIONS; HUMANS; LINEAR MODELS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIANS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0031038776     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Chin J, Sato PA, Mann JM. Projections of HIV infections and AIDS cases to the year 2000. Bulletin WHO 1990; 68: 1-11.
2. Owens DK, Nease RF, Harris RA. Cost-effectiveness of HIV screening in acute care settings. Arch Intern Med 1996; 156: 394-404.
3. Wu AW, Mathews WC, Brysk LT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acquir Immun Defic Syndr 1990; 3: 683-690.
4. Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The quality of well-being scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989; 27: S27-S43.
5. Tsevat J, Solzan JG, Kuntz KM, et al. Health values of patients infected with human immunodeficiency virus. Med Care 1996; 34: 44-57.
6. O'Dell MW, Lubeck DP, O'Driscoll P, Matsuno S. Validity of the Karnofsky Performance Status in an HIV-infected sample. J Acquir Immune Defic Syndr 1995; 10: 350-357.
7. Revicki DA, Brown RE, Henry DH, McNeill MV, Rios A, Watson T. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 1994; 7: 474-484.
8. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: Measurement by the medical outcomes study instrument. Ann Intern Med 1992; 116: 129-137.
9. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Med Care 1991; 29: 786-798.
10. Revicki DA, Simpson KN, Wu AW, LaVallee RL. Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-Twist and multiattribute utility techniques. Qual Life Res 1995; 4: 309-318.
11. Gelber RD, Lenderking WR, Cotton DJ, et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. Ann Intern Med 1992; 116: 961-966.
12. Bozzette S, Kanouse D, Berry S, Duan N. Health status and function with zidovudine or zalcitabine as initial therapy for AIDS. A randomized controlled trial. JAMA 1995; 273: 295-301.
13. Cleary PD, Fowler FJ, Jr., Weissman J, et al. Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care 1993; 31: 569-580.
14. Lenderking WR, Gelber RD, Cotton DJ, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med 1994; 330: 738-743.
15. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med 1978; 299: 1397-1401.
16. McNeil B, Weichselbaum R, Pauker S. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981; 305: 982-987.
17. Owens DK, Nease RF. Occupational exposure to human immunodeficiency virus (HIV) and hepatitis B (HBV): a comparative analysis of risk. Am J Med 1992; 92: 503-512.
18. Owens DK, Nease RF. Transmission of human immunodeficiency virus (HIV) infection between physicians and patients: a model-based analysis of risk. In: Kaplan E, Brandeau ML, eds. Modeling the AIDS Epidemic: Planning, Policy, and Prediction. New York, NY: Raven Press, 1994: 153-177.
19. Owens DK, Harris RA, Scott PM, Nease RF. Screening surgeons for HIV infection: A cost-effectiveness analysis. Ann Intern Med 1995; 122: 641-652.
20. Nease RF, Jr, Kneeland T, O'Connor GT, et al. Variation in patient utilities for the outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 1995; 273: 1185-1190.
21. Owens DK, Sox HC, Jr. Medical decision making: Probabilistic medical reasoning. In: Shortliffe E, Perreault L, Wiederhold G, Fagan L, eds. Medical Informatics: Computer Applications in Health Care. Reading, MA: Addison-Wesley, 1990: 70-116.
22. Weinstein MC, Fineberg H. Clinical Decision Analysis. Philadelphia, PA: Saunders, 1980.
23. Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995; 274: 1839-1845.
24. Revicki DA, Wu AW, Murray MI. Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Medical Care 1995; 33(Suppl 4): AS173-AS182.
25. Sanders GD, Owens DK, Padian N, Cardinalli AB, Sullivan AN, Nease RF. A computer-based interview to identify HIV risk behaviors and to assess patient preferences for HIV-related health states. Proceedings of the Eighteenth Annual Symposium on Computer Applications in Medical Care. Washington, DC, 1994: 20-24.
26. Torrance GW. Social preferences for health states. An empirical evaluation of three measurement techniques. Socio-Econ Planning 1976; 10: 129-136.
27. Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Int Med 1996; 156: 1829-1836.
28. Nease RF, Jr, Hynes LH, Littenberg B. Automated utility assessment of global health. Qual Life Res 1996; 5: 175-182.
29. Sumner W, Nease R, Littenberg B. U-titer: A utility assessment tool. Proceedings of the Fifteenth Annual Symposium on Computer Applications in Medical Care. Washington, DC 1991: 701-705.
30. Lenert LA, Michelson D, Flowers C, Bergen MR. IMPACT: an object-oriented graphical environment for construction of multimedia patient interviewing software. Proceedings of the Nineteenth Annual Symposium on Computer Applications in Medical Care. Washington, DC, 1995: 319-323.
31. CDC. Update: Provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996; 45: 469-472.
32. CDC. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. MMWR 1995; 44: 929-933.
33. Zug KA, Littenberg B, Baughman RD, et al. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Arch Dermatol 1995; 131: 561-568.
34. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993; 13: 89-102.
35. Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45: 505-512.
36. Nease R, Hynes L, Littenberg B, Tosteson A, Sumner W, Owens D. Variation in patient preferences for outcomes associated with the management of mild hypertension: Implications for practice guidelines. Abstracts of the Eleventh Annual Meeting of the Association for Health Services Research and Foundation for Health Services. San Diego, CA, 1994: 25.